Calcium Channel Blocker Market Will Cross USD 15.31 Billion in 2022

Business Dec 28, 2017 No Comments

Zion Market Research has published a new report titled “Calcium Channel Blocker Market by Drug class (Dihydropyridine and Non-Dihydropyridine) for Hypertension, Angina Pectoris, Pregnancy, Obesity and Other – Global Industry Perspective, Comprehensive Analysis, and Forecast, 2016 – 2022”. According to the report, the global calcium channel blocker market accounted for USD 11.26 billion in 2016 and is expected to reach USD 15.31 billion, growing at a CAGR of around 5.4% between 2017 and 2022.

Calcium Channel Blocker Market

Calcium Channel Blocker Market

Calcium channel blockers (CCBs) or calcium antagonists are among the most widely used drugs in cardiovascular medicine. CCBs promote vasodilator activity and thus act by reducing calcium influx into vascular smooth muscle cells by interfering with voltage-operated calcium channels in the cell membrane. This activity of calcium channel blockers helps for treating Hypertension and various other cardiovascular diseases.

Year-end sale Flat 30% off

The market of global calcium channel blocker has been accelerated by rising prevalence of hypertension across the globe. Moreover, calcium channel blockers are an essential class of cardiovascular drug prescribed by a physician for the treatment of hypertension which helps in propelling the growth of calcium channel blocker market. Furthermore, its wide application in pharmaceutical industry is expected to fuel the growth of global calcium channel blocker market. As well, the rising percentage of the obese population is also considered as a major driving factor for the growth of CCB market.  However, availability of alternatives and certain side effect of CCB can restrict the growth of calcium channel blocker market. Nonetheless, ongoing research and development and combination therapy will serve as major opportunities for upcoming growth of calcium channel blocker market.

Request Free Sample Research Report @

Purchase this report with flat 30 discount(avail single user license at US $2939)

Based on product, calcium channel blocker market segmented into two types: Dihydropyridine and Non-Dihydropyridine. Dihydropyridine market is further sub-segmented into Amlodipine, Cilnidipine, Felodipine, Verapamil, Diltiazem, Isradipine, Nicardipine, Nisoldipine, Nifedipine and others. In 2016, amlodipine held the largest market share in terms of total revenue generation in the Dihydropyridine market.  This growth is attributed due to the most preference by the physician or consultant towards amlodipine over the other drugs.

Based on application, calcium channel blocker market segmented into five types: hypertension, angina pectoris, pregnancy, anti-obesity and other. Hypertension dominated the calcium channel blockers market in 2016. This segment accounted for the largest market share in term of revenue generation in 2016. The growth of hypertension market is attributed due to large hypertension patient population than any other illness which can be treated by CCB.

Browse detail report with in-depth TOC @

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global calcium channel blocker include Pfizer Inc., AstraZeneca plc., bayer healthcare llc., GlaxoSmithKline plc., Sanofi S.A., Johnson & Johnson, Abcam, AbMole Bioscience, and Clearsynth.

For Media Inquiry contact our sales Team @

About Us: Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research

4283, Express Lane,

Suite 634-143,

Sarasota, Florida 34249, United States

Tel: +49-322 210 92714

USA/Canada Toll-Free No.1-855-465-4651



Visit Our



Shawn Morgan is an accomplished digital marketing professional. He tracks the most recent patterns and happenings in the advanced showcasing scene, additionally offering his feeling on their effect on organizations. He has involvement in both B2C and B2B markets. His side interests incorporate perusing books and voyaging. Follow him on Twitter: @shawnmorgan789